ewopharma: Search

1. About Ewopharma

… EWOPHARMA KEYFACTS OUR STRATEGY TERRITORY OUR VALUES CORPORATE RESPONSIBILITY VISION/MISSION LEADERSHIP About Ewopharma Ewopharma is the successor company to M.R. Leclerc & Co., founded in 1959. From the…

2. Neomed s.r.o. becomes part of Ewopharma Group

… Schaffhausen, 01/06/23 – Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to announce its acquisition of Neomed s.r.o., a Czech Distribution company of…

3. Ewopharma

4. Ewopharma launches new Corporate Design

… Schaffhausen, 12th April 2019 – Getting 60 years in 2019 Ewopharma decided for a new appearance. The adjustments that have been made are a cautious and contemporary development – an evolution not a revolution. The new…

5. Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

… Schaffhausen, Switzerland, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of…

6. Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

… diseases, today announced it has signed an exclusive distribution agreement with Switzerland-based Ewopharma for Piclidenoson in the treatment of psoriasis and Namodenoson in the treatment of liver diseases…

7. Ewopharma and Vianex announce collaboration to distribute the essential antibiotic Amikacin in Switzerland

… Schaffhausen, 29 July 2019 – Ewopharma and Vianex S.A. are pleased to announce their new partnership for distribution of Amikacin in Switzerland. Ewopharma will be the new market authorisation holder for the drug and…

8. Ewopharma strengthens its oncology business

… Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of 1st…

9. Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)

… someone else. To learn more please check: www.proibs.eu. Calmino group AB (Gothenburg, Sweden) and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the…

10. Ewopharma and Eisai announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib)

… SCHAFFHAUSEN, SWITZERLAND and HATFIELD, UK, 26th March, 2020 – Ewopharma, a pharmaceutical marketing company and Eisai Europe Ltd., a leading global research and development-based pharmaceutical company are pleased to…